These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25857341)

  • 1. Advances in Alzheimer's disease drug development.
    Rafii MS; Aisen PS
    BMC Med; 2015 Mar; 13():62. PubMed ID: 25857341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can We Treat Neuroinflammation in Alzheimer's Disease?
    Sánchez-Sarasúa S; Fernández-Pérez I; Espinosa-Fernández V; Sánchez-Pérez AM; Ledesma JC
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatments in Alzheimer's disease.
    Briggs R; Kennelly SP; O'Neill D
    Clin Med (Lond); 2016 Jun; 16(3):247-53. PubMed ID: 27251914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-dementia Alzheimer's trials: overview.
    Aisen PS
    J Nutr Health Aging; 2010 Apr; 14(4):294. PubMed ID: 20305998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and clinical trials.
    Paul D; Agrawal R; Singh S
    J Basic Clin Physiol Pharmacol; 2024 Jan; 35(1-2):31-44. PubMed ID: 38491747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and novel therapeutic molecules and targets in Alzheimer's disease.
    Kumar A; Nisha CM; Silakari C; Sharma I; Anusha K; Gupta N; Nair P; Tripathi T; Kumar A
    J Formos Med Assoc; 2016 Jan; 115(1):3-10. PubMed ID: 26220908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
    Ehret MJ; Chamberlin KW
    Clin Ther; 2015 Aug; 37(8):1604-16. PubMed ID: 26122885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis.
    Matsunaga S; Kishi T; Iwata N
    PLoS One; 2015; 10(4):e0123289. PubMed ID: 25860130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
    Siemers ER; Sundell KL; Carlson C; Case M; Sethuraman G; Liu-Seifert H; Dowsett SA; Pontecorvo MJ; Dean RA; Demattos R
    Alzheimers Dement; 2016 Feb; 12(2):110-120. PubMed ID: 26238576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the prevention of Alzheimer's Disease.
    Sindi S; Mangialasche F; Kivipelto M
    F1000Prime Rep; 2015; 7():50. PubMed ID: 26097723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions.
    Andrieu S; Coley N; Lovestone S; Aisen PS; Vellas B
    Lancet Neurol; 2015 Sep; 14(9):926-944. PubMed ID: 26213339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's Disease: Mechanism and Approach to Cell Therapy.
    Amemori T; Jendelova P; Ruzicka J; Urdzikova LM; Sykova E
    Int J Mol Sci; 2015 Nov; 16(11):26417-51. PubMed ID: 26556341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in Alzheimer's disease.
    Zare-Shahabadi A; Masliah E; Johnson GV; Rezaei N
    Rev Neurosci; 2015; 26(4):385-95. PubMed ID: 25870960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
    Komuro Y; Xu G; Bhaskar K; Lamb BT
    Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody drugs for Alzheimer's show glimmers of promise.
    Reardon S
    Nature; 2015 Jul; 523(7562):509-10. PubMed ID: 26223602
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment for Alzheimer's disease: has anything changed?
    Waite LM
    Aust Prescr; 2015 Apr; 38(2):60-3. PubMed ID: 26648618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning in Alzheimer's disease.
    Corbett A; Williams G; Ballard C
    Front Biosci (Schol Ed); 2015 Jun; 7(1):184-8. PubMed ID: 25961694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.
    Nygaard HB; Wagner AF; Bowen GS; Good SP; MacAvoy MG; Strittmatter KA; Kaufman AC; Rosenberg BJ; Sekine-Konno T; Varma P; Chen K; Koleske AJ; Reiman EM; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2015; 7(1):35. PubMed ID: 25874001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein.
    Folch J; Ettcheto M; Petrov D; Abad S; Pedrós I; Marin M; Olloquequi J; Camins A
    Neurologia (Engl Ed); 2018; 33(1):47-58. PubMed ID: 25976937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.